Sorting out the new HSV type specific antibody tests
Clicks: 513
ID: 112394
2001
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
67.3
/100
513 views
352 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #1 of 10 articles by views in sexually transmitted infections
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This review will delineate performance characteristics and limitations, as far as they are known, of the new glycoprotein G based, type specific HSV serologies. Several of these tests have been FDA approved in the United States for use in adults. With the departure of Gull/Meridian from the HSV sero …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (50 words).
Try re-searching for a better abstract.
| Reference Key |
rl2001sexuallysorting
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ashley RL;; |
| Journal | sexually transmitted infections |
| Year | 2001 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
pregnancy
adult
female
male
adolescent
aged
middle aged
Child
Infant
preschool
sensitivity and specificity
antibody specificity*
enzyme-linked immunosorbent assay
reagent kits
herpes genitalis / transmission
herpes simplex / transmission
viral envelope proteins
blotting
western
pmid:11463920
pmc1744343
doi:10.1136/sti.77.4.232
r l ashley
benchmarking
cross reactions / immunology
drug approval
herpes genitalis / diagnosis*
herpes simplex / diagnosis*
herpesvirus 1
human / immunology*
herpesvirus 2
point-of-care systems / standards
diagnostic / standards*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.